Sangamo Therapeutics

In News

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Short Interest Update - MarketBeat

MarketBeat - Mar 02, 2026

Sangamo Therapeutics (SGMO) Shares Stabilize Amid Recent Key Pipeline Update - Yahoo Finance

Yahoo Finance - Jan 12, 2026

Sangamo Starts Putting BLA for Fabry Disease Gene Therapy Isa-Vec in Front of FDA - CGTLive®

CGTLive® - Dec 19, 2025

Sangamo plans earlier filing of Fabry gene therapy after FDA meeting - FirstWord Pharma

FirstWord Pharma - Nov 21, 2025

Sangamo Therapeutics (Nasdaq: SGMO) gets FDA Fast Track for ST-503 in small fiber neuropathy - Stock Titan

Stock Titan - Dec 02, 2025

Eli Lilly to leverage Sangamo capsid technology for CNS disease therapies - MSN

MSN - Jan 19, 2026

How Recent Developments Are Rewriting the Story for Sangamo Therapeutics - Yahoo Finance

Yahoo Finance - Nov 27, 2025

How the Narrative Surrounding Sangamo Therapeutics Is Shifting After New Regulatory and Valuation Signals - Yahoo Finance

Yahoo Finance - Dec 12, 2025

How The Pulled Price Target Is Reshaping The Story For Sangamo Therapeutics (SGMO) - Yahoo Finance

Yahoo Finance - Jan 23, 2026

Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2025 Financial Results - Yahoo Finance

Yahoo Finance - Nov 06, 2025

Why The Narrative Around Sangamo Therapeutics Is Shifting After Recent Analyst and FDA Updates - Yahoo Finance

Yahoo Finance - Nov 07, 2025

Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease - Yahoo Finance

Yahoo Finance - Nov 21, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment